Basic Information
Amlogenyx is a subsidiary company focused on developing novel gene therapies for Alzheimer's disease based on the lysosomal approach.
Amlogenyx
United States of America
unclear
January 01, 2023
--
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios